| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	2-hydroxysuccinaldehyde
				
			5-FU
				
			5-aza-2'-deoxycytidine
				
			A77 1726
				
			BPTI
				
			Bivalirudin
				
				
					Myocardial infarction: postmarketing CAS 76095-16-4
				
				
					Myocardial infarction: 1.2% CAS 76420-72-9
				
				
					Myocardial infarction: postmarketing Cancidas
				
			Eptifibatide
				
				
					Myocardial infarction: 0.0962% Estrofem
				
			FAMP
				
			FK463
				
			Fe(III
				
			Gd-DTPA
				
			Ge-132
				
			Glat copolymer
				
				
					Myocardial infarction: postmarketing Goserelin
				
				
					Myocardial infarction: postmarketing Insulin
				
			K779
				
			L-Dmp
				
				
					Myocardial infarction: rare LMWH
				
			Lantus
				
			Leuprorelin
				
				
					Myocardial infarction: postmarketing Lisinopril
				
				
					Myocardial infarction: postmarketing, uncommon Lovaza
				
			Meropenem anhydrous
				
			Nafarelin
				
				
					Myocardial infarction: postmarketing Oestrogen
				
				
					Myocardial infarction: rare PGE1
				
			PGE2
				
			Photofrin
				
			SU5416
				
			SonoVue
				
			Stalevo 50
				
			Terlipressin
				
				
					Myocardial infarction: postmarketing Triptorelin
				
				
					Myocardial infarction: postmarketing Trisequens
				
			UDCA
				
			abacavir
				
				
					Myocardial infarction: postmarketing abiraterone
				
			acamprosate
				
				
					Myocardial infarction: infrequent adenosine
				
				
					Myocardial infarction: postmarketing almotriptan
				
			amifostine
				
			amitriptyline
				
			amlodipine besylate
				
			amoxapine
				
				
					Myocardial infarction: postmarketing amphetamine
				
			amphotericin B
				
			amprenavir
				
				
					Myocardial infarction: postmarketing anagrelide
				
			anastrozole
				
				
					Myocardial infarction: 1.29% - 1.36% anthracycline
				
			aprepitant
				
			argatroban
				
				
					Myocardial infarction: 3.57% - 3.6% aripiprazole
				
			atenolol
				
				
					Myocardial reinfarction: 0% - 6% atropine
				
			axitinib
				
				
					Myocardial infarction: 1.4% benazepril
				
			betaxolol
				
			bezafibrate
				
			bicalutamide
				
			bisoprolol
				
			bleomycin hydrochloride
				
			bortezomib
				
			bosentan
				
			bromocriptine
				
				
					Myocardial infarction: postmarketing bupropion
				
				
					Myocardial infarction: postmarketing, rare buspirone
				
				
					Myocardial infarction: rare candesartan
				
			candesartan cilexetil
				
			capecitabine
				
			carbidopa
				
			carboplatin
				
			carvedilol
				
				
					Myocardial infarction: 0.9% - 2.2% cefdinir
				
				
					Myocardial infarction: postmarketing celecoxib
				
			cevimeline
				
			cilazapril
				
				
					Myocardial infarction: postmarketing, 0.1% - 0.3% cilostazol
				
			ciprofloxacin
				
				
					Myocardial infarction: postmarketing cisplatin
				
			citalopram
				
				
					Myocardial infarction: postmarketing, infrequent, uncommon clevidipine
				
			clomipramine
				
				
					Myocardial infarction: rare clozapine
				
				
					Myocardial infarction: postmarketing colesevelam
				
			colestyramine
				
			conjugated estrogens
				
				
					Myocardial infarction: postmarketing copolymer 1
				
				
					Myocardial infarction: postmarketing cortisol
				
			cortisone
				
			cyclobenzaprine
				
				
					Myocardial infarction: postmarketing cyclophosphamide
				
				
					Myocardial infarction: postmarketing Myocardial necrosiscyproterone
				
				
					Myocardial infarction: 4% cyproterone acetate
				
			dabigatran
				
			dabigatran etexilate
				
			dalteparin
				
			danazol
				
			dapagliflozin
				
			darunavir
				
				
					Myocardial infarction: uncommon, 0.2% dasatinib
				
			degarelix
				
			deprenyl
				
				
					Myocardial infarction: rare desflurane
				
				
					Myocardial infarction: postmarketing desipramine
				
			desvenlafaxine
				
			dexamethasone
				
			dexamethasone sodium phosphate
				
			dexmedetomidine
				
				
					Myocardial infarction: postmarketing diatrizoate
				
			diazepam
				
			diclofenac
				
				
					Myocardial infarction: very rare dihydroergotamine
				
				
					Myocardial infarction: postmarketing diltiazem
				
				
					Myocardial infarction: postmarketing dipyridamole
				
			docetaxel
				
				
					Myocardial infarction: very rare, postmarketing dofetilide
				
			dolasetron
				
				
					Myocardial infarction: postmarketing donepezil
				
				
					Myocardial infarction: infrequent dorzolamide
				
			dothiepin
				
			doxazosin
				
				
					Myocardial infarction: postmarketing, 1% - 1.3% drospirenone (DRSP
				
			duloxetine
				
				
					Myocardial infarction: postmarketing, infrequent eletriptan
				
			entacapone
				
				
					Myocardial infarction: uncommon, common epinephrine
				
			eplerenone
				
				
					Myocardial infarction: common ergonovine
				
			erlotinib
				
			esmolol
				
				
					Myocardial infarctionInferior myocardial infarctionestradiol
				
				
					Myocardial infarction: postmarketing estradiol cypionate
				
			estradiol valerate
				
			estramustine
				
				
					Myocardial infarction: 1% - 3% estramustine phosphate
				
			estriol
				
			estrone
				
			etodolac
				
				
					Myocardial infarction: postmarketing etoposide
				
			etoricoxib
				
			etravirine
				
			everolimus
				
			exemestane
				
			febuxostat
				
			fenofibrate
				
			fenoldopam
				
			ferumoxytol
				
				
					Myocardial infarction: postmarketing fludarabine
				
				
					Myocardial infarction: 0% - 3% fluoxetine
				
				
					Myocardial infarction: infrequent flurbiprofen
				
			fluvoxamine
				
				
					Myocardial infarction: rare, infrequent formoterol
				
			fosamprenavir
				
				
					Myocardial infarction: uncommon fosinopril
				
			fosinoprilat
				
			frovatriptan
				
			gabapentin
				
				
					Myocardial infarction: rare, infrequent gadodiamide
				
			gemcitabine
				
				
					Myocardial infarction: postmarketing, rare gemeprost
				
			gliclazide
				
			guanfacine
				
				
					Myocardial infarction: postmarketing heparin
				
			hydrochlorothiazide
				
			ibuprofen
				
			idarubicin
				
			ifosfamide
				
				
					Myocardial infarction: postmarketing imatinib
				
				
					Myocardial infarction: rare imipramine
				
			imiquimod
				
				
					Myocardial infarction: postmarketing indinavir
				
				
					Myocardial infarction: postmarketing insulin detemir
				
			iodixanol
				
			iopamidol
				
			iopromide
				
				
					Myocardial infarction: postmarketing ioversol
				
			ioxaglate
				
			irbesartan
				
				
					Myocardial infarction: rare irbesartan-hydrochlorothiazide
				
			irinotecan
				
			iron sucrose
				
			isomannide
				
			isosorbide-5-mononitrate
				
			isradipine
				
			ixabepilone
				
			ketoprofen
				
				
					Myocardial infarction: postmarketing ketorolac
				
				
					Myocardial infarction: postmarketing ketorolac tromethamine
				
			lamotrigine
				
				
					Myocardial infarction: rare lanreotide
				
			lansoprazole
				
			lenalidomide
				
				
					Myocardial infarction: postmarketing lercanidipine
				
			letrozole
				
				
					Myocardial infarction: 0.276% - 15% leuprorelin acetate
				
			levodopa/carbidopa
				
			lisdexamfetamine dimesylate
				
				
					Myocardial infarction: postmarketing lomefloxacin
				
			maprotiline
				
			maraviroc
				
			medroxyprogesterone
				
			medroxyprogesterone acetate
				
			mefenamic acid
				
			meloxicam
				
				
					Myocardial infarction: postmarketing memantine
				
				
					Myocardial infarction: infrequent meropenem
				
			methylphenidate
				
			methylprednisolone
				
			methylprednisolone sodium succinate
				
			metipranolol
				
			mirtazapine
				
				
					Myocardial infarction: postmarketing, infrequent misoprostol
				
				
					Myocardial infarction: postmarketing mitoxantrone
				
			moexiprilat
				
			moxifloxacin
				
			mycophenolate mofetil
				
			nabumetone
				
				
					Myocardial infarction: postmarketing, 0.1% naltrexone
				
			naproxen
				
			naratriptan
				
				
					Myocardial infarction: very rare nebivolol
				
				
					Myocardial infarction: postmarketing nicardipine
				
				
					Myocardial infarction: 0.6% nicorandil
				
				
					Myocardial infarction: uncommon nilotinib
				
				
					Myocardial infarction: uncommon nisoldipine
				
			norethisterone
				
			norfloxacin
				
			nortriptyline
				
			ofloxacin
				
			ogen
				
			ondansetron
				
				
					Myocardial infarction: postmarketing oxaprozin
				
			paclitaxel
				
				
					Myocardial infarction: rare, common pantoprazole
				
			parecoxib
				
			paroxetine
				
				
					Myocardial infarction: rare pazopanib
				
			pemetrexed
				
			pergolide
				
				
					Myocardial infarction: infrequent, 1.1% perindopril
				
				
					Myocardial infarction: very rare phentermine
				
			phentolamine
				
				
					Myocardial infarction: common phenylephrine
				
			pilocarpine
				
			pioglitazone
				
			piroxicam
				
			ponatinib
				
				
					Myocardial infarction: 2.9% posaconazole
				
			potassium phosphate
				
				
					Myocardial infarction: rare pramipexole
				
			pravastatin
				
				
					Myocardial infarction: 0.5% prednisolone
				
			prednisolone acetate
				
			prednisone
				
			pregabalin
				
				
					Myocardial infarction: infrequent propofol
				
			propoxyphene
				
			prostacyclin
				
			protriptyline
				
			quinapril
				
			rabeprazole
				
			raltegravir
				
			ramipril
				
				
					Myocardial infarction: 0.3% - 1.7% rasagiline
				
				
					Myocardial infarction: infrequent, uncommon regadenoson
				
				
					Myocardial infarction: postmarketing, uncommon regorafenib
				
			repaglinide
				
			rescinnamine
				
				
					Myocardial infarction: 1.4% retinoic acid
				
			ribavirin
				
				
					Myocardial infarction: uncommon riluzole
				
				
					Myocardial infarction: infrequent risperidone
				
				
					Myocardial infarction: infrequent ritonavir
				
				
					Myocardial infarction: postmarketing rivastigmine
				
				
					Myocardial infarction: frequent rizatriptan
				
				
					Myocardial infarction: postmarketing rofecoxib
				
			ropinirole
				
				
					Myocardial infarction: infrequent ropivacaine
				
			rosiglitazone
				
			salmon calcitonin acetate
				
			sertraline
				
				
					Myocardial infarction: postmarketing, rare sibutramine
				
			sildenafil
				
				
					Myocardial infarction: postmarketing, rare sitaxsentan
				
			sodium
				
			sodium ferric gluconate
				
			sorafenib
				
			sotalol
				
			strontium ranelate
				
			sumatriptan
				
				
					Myocardial infarction: very rare tacrolimus
				
				
					Myocardial infarction: postmarketing tadalafil
				
				
					Myocardial infarction: postmarketing tamoxifen
				
			telmisartan
				
				
					Myocardial infarction: postmarketing tenoxicam
				
			testosterone
				
				
					Myocardial infarction: postmarketing tetrahydrobiopterin
				
			thalidomide
				
				
					Myocardial infarction: postmarketing thyroxine
				
			tiagabine
				
				
					Myocardial infarction: infrequent tibolone
				
			tirofiban
				
			tizanidine
				
				
					Myocardial infarction: rare tolcapone
				
				
					Myocardial infarction: infrequent toremifene
				
				
					Myocardial infarction: 0.498% - 1.4% tramadol
				
			trandolapril
				
				
					Myocardial infarction: postmarketing trandolaprilat
				
				
					Myocardial infarction: postmarketing tranexamic acid
				
			trazodone
				
				
					Myocardial infarction: postmarketing triamcinolone
				
			triamcinolone acetonide
				
			triiodothyronine
				
			trimipramine
				
			ustekinumab
				
			v 1784
				
				
					Myocardial infarction: postmarketing valdecoxib
				
			vardenafil
				
			varenicline
				
				
					Myocardial infarction: postmarketing, infrequent venlafaxine
				
				
					Myocardial infarction: rare verapamil
				
				
					Myocardial infarction: postmarketing verteporfin
				
			vinblastine
				
			vincristine
				
			vinflunine
				
			vinorelbine
				
			voriconazole
				
			vorinostat
				
			zolmitriptan
				
				
					Myocardial infarction: postmarketing, rare zolpidem
				
				
					Myocardial infarction: rare  | Drugs with this indication |